Back to Browse Journals » Patient Preference and Adherence » Volume 5

Concurrent validity of kidney transplant questionnaire in US renal transplant recipients

Authors Chisholm-Burns MA, Erickson SR, Spivey CA, Gruessner RWG, Kaplan B

Published Date October 2011 Volume 2011:5 Pages 517—522

DOI http://dx.doi.org/10.2147/PPA.S24261

Published 13 October 2011

Marie A Chisholm-Burns1,2, Steven R Erickson3, Christina A Spivey1, Rainer WG Gruessner2, Bruce Kaplan4
1Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, AZ; 2Department of Surgery, University of Arizona College of Medicine, Tucson, AZ; 3Department of Clinical Sciences, University of Michigan College of Pharmacy, Ann Arbor, MI; 4Department of Medicine, The University of Arizona College of Medicine Tucson, AZ, USA

Background: Valid instrumentation in the assessment of health-related quality of life (HQoL) in renal transplant recipients is critical to identifying particular nuances and determinants of HQoL in this population. Therefore, the validity of disease-specific instruments to measure HQoL in renal transplant recipients, such as the Kidney Transplant Questionnaire (KTQ), needs further investigation. The objective of this study was to assess the concurrent validity of the KTQ in adult US renal transplant recipients using the well established SF-12 Health Survey version 2 (SF-12v2) as the comparison instrument.
Methods: One hundred and fourteen renal transplant recipients met the following inclusion criteria for this study, ie, were at least 21 years of age, more than two years post-transplant, and receiving immunosuppressant therapy. Subjects were asked to complete a series of HQoL instruments, ie, the KTQ and the SF-12v2 (physical component summary [PCS-12] and mental component summary [MCS-12]). Descriptive statistics were calculated, and correlational analyses were conducted to examine the concurrent validity of the HQoL instruments.
Results: Among 100 participants (87.7% response rate), the majority of participants were male (52%), had deceased donor transplants (63%), and received Medicare benefits (84%). PCS-12 was positively correlated with three of five KTQ subscales (P < 0.05), ie, KTQ-physical (r = 0.43), KTQ-fatigue (r = 0.42), and KTQ-uncertainty/fear (r = 0.2). MCS-12 was positively correlated with all KTQ subscales (P < 0.01), ie, KTQ-physical (r = 0.26), KTQ-fatigue (r = 0.48), KTQ-uncertainty/fear (r = 0.33), KTQ-emotional (r = 0.47), and KTQ-appearance (r = 0.28).
Conclusion: The findings support the concurrent validity of the KTQ in US renal transplant recipients. Future studies should continue exploring the validity of the KTQ, as well as its practical and research utility in HQoL measurement in the renal transplant population.

Keywords: concurrent validity, kidney transplant questionnaire, quality of life, renal transplant recipients, SF-12 Health Survey

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Impact of clinical pharmacy services on renal transplant recipients’ adherence and outcomes

Marie A Chisholm-Burns, Christina A Spivey, Charlene Garrett, Herbert McGinty, Laura L Mulloy

Patient Preference and Adherence 2008, 2:287-292

Published Date: 17 October 2008

Readers of this article also read:

Is there an association between immunosuppressant therapy medication adherence and depression, quality of life, and personality traits in the kidney and liver transplant population?

Gorevski E, Succop P, Sachdeva J, Cavanaugh TM, Volek P, Heaton P, Chisholm-Burns M, Martin-Boone JE

Patient Preference and Adherence 2013, 7:301-307

Published Date: 16 April 2013

Cardiovascular risk factor investigation: a pediatric issue

Rodrigues AN, Abreu GR, Resende RS, Goncalves WL, Gouvea SA

International Journal of General Medicine 2013, 6:57-66

Published Date: 5 March 2013

Clinical evaluation of a noninvasive technology for the treatment of chronic joint symptoms

Chelucci KM, Shapiro RS, White DB, Bachmann K

Orthopedic Research and Reviews 2013, 5:5-11

Published Date: 16 January 2013

Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation

Castagna A, Rinaldi S, Fontani V, Mannu P, Lotti Margotti M

Clinical Interventions in Aging 2011, 6:201-206

Published Date: 25 July 2011

Comparison of avian and nonavian hyaluronic acid in osteoarthritis of the knee

Robert J Petrella, Anthony Cogliano, Joseph Decaria

Orthopedic Research and Reviews 2010, 2:5-9

Published Date: 20 January 2010

Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity

Joseph Finkelstein, Eunme Cha, Steven M Scharf

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:337-349

Published Date: 4 September 2009

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009